A detailed history of State Of Wisconsin Investment Board transactions in Biogen Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 79,395 shares of BIIB stock, worth $13.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
79,395
Previous 88,563 10.35%
Holding current value
$13.8 Million
Previous $19.1 Million 3.62%
% of portfolio
0.05%
Previous 0.05%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$190.52 - $236.72 $1.75 Million - $2.17 Million
-9,168 Reduced 10.35%
79,395 $18.4 Million
Q1 2024

May 14, 2024

BUY
$212.02 - $267.71 $2.33 Million - $2.95 Million
11,001 Added 14.18%
88,563 $19.1 Million
Q4 2023

Feb 12, 2024

SELL
$222.59 - $267.94 $830,038 - $999,148
-3,729 Reduced 4.59%
77,562 $20.1 Million
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $7.65 Million - $8.64 Million
-30,207 Reduced 27.09%
81,291 $20.9 Million
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $3.49 Million - $4.03 Million
12,677 Added 12.83%
111,498 $31.8 Million
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $1.4 Million - $1.59 Million
5,448 Added 5.83%
98,821 $27.5 Million
Q4 2022

Feb 14, 2023

BUY
$252.44 - $306.72 $95,927 - $116,553
380 Added 0.41%
93,373 $25.9 Million
Q3 2022

Nov 14, 2022

SELL
$194.69 - $268.46 $5.48 Million - $7.56 Million
-28,169 Reduced 23.25%
92,993 $24.8 Million
Q2 2022

Aug 15, 2022

SELL
$187.54 - $223.02 $1.41 Million - $1.67 Million
-7,506 Reduced 5.83%
121,162 $24.7 Million
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $1.34 Million - $1.68 Million
-6,895 Reduced 5.09%
128,668 $27.1 Million
Q4 2021

Feb 11, 2022

SELL
$223.92 - $287.77 $4.38 Million - $5.63 Million
-19,549 Reduced 12.6%
135,563 $32.5 Million
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $38.6 Million - $50.4 Million
-136,451 Reduced 46.8%
155,112 $43.9 Million
Q2 2021

Aug 12, 2021

BUY
$259.0 - $414.71 $36.4 Million - $58.2 Million
140,375 Added 92.85%
291,563 $101 Million
Q1 2021

May 17, 2021

SELL
$242.95 - $284.63 $8.81 Million - $10.3 Million
-36,247 Reduced 19.34%
151,188 $42.3 Million
Q4 2020

Feb 03, 2021

BUY
$236.26 - $355.63 $16.2 Million - $24.4 Million
68,634 Added 57.77%
187,435 $45.9 Million
Q3 2020

Nov 16, 2020

BUY
$264.77 - $305.71 $4.21 Million - $4.86 Million
15,911 Added 15.46%
118,801 $33.7 Million
Q2 2020

Aug 12, 2020

SELL
$258.66 - $342.55 $1.41 Million - $1.86 Million
-5,439 Reduced 5.02%
102,890 $27.5 Million
Q1 2020

May 06, 2020

SELL
$268.85 - $341.04 $12.6 Million - $16 Million
-46,984 Reduced 30.25%
108,329 $34.3 Million
Q4 2019

Feb 14, 2020

SELL
$220.06 - $304.07 $6.32 Million - $8.73 Million
-28,708 Reduced 15.6%
155,313 $46.1 Million
Q3 2019

Nov 12, 2019

SELL
$217.44 - $243.88 $15.5 Million - $17.3 Million
-71,055 Reduced 27.86%
184,021 $42.8 Million
Q2 2019

Aug 14, 2019

SELL
$219.29 - $241.72 $8.27 Million - $9.11 Million
-37,708 Reduced 12.88%
255,076 $59.7 Million
Q1 2019

May 13, 2019

SELL
$216.71 - $338.96 $298,409 - $466,747
-1,377 Reduced 0.47%
292,784 $69.2 Million
Q4 2018

Feb 11, 2019

BUY
$278.5 - $352.75 $7.05 Million - $8.93 Million
25,310 Added 9.41%
294,161 $88.5 Million
Q3 2018

Nov 14, 2018

SELL
$293.51 - $383.83 $25.6 Million - $33.5 Million
-87,182 Reduced 24.49%
268,851 $95 Million
Q2 2018

Aug 03, 2018

SELL
$257.52 - $306.91 $3.66 Million - $4.36 Million
-14,214 Reduced 3.84%
356,033 $103 Million
Q1 2018

May 07, 2018

BUY
$260.13 - $367.91 $10.2 Million - $14.5 Million
39,382 Added 11.9%
370,247 $101 Million
Q4 2017

Feb 08, 2018

SELL
$307.64 - $344.58 $5.35 Million - $5.99 Million
-17,395 Reduced 4.99%
330,865 $105 Million
Q3 2017

Nov 01, 2017

BUY
$281.15 - $329.69 $97.9 Million - $115 Million
348,260
348,260 $109 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.